Internal Medicine · Acibadem Adana Hospital Assoc. Prof. Umut Dişel, MD
✓ Medically verified profileAssoc. Prof. Umut Dişel, MD
Assoc. Prof. Umut Dişel, MD is an Internal Medicine specialist working in Medical Oncology at Acibadem Adana Hospital in Adana, Turkey. He treats anemia and a broad range of cancers, including breast, lung, colorectal, gastric, liver, pancreatic, kidney and prostate cancer, lymphoma, oral cancer and malignant melanoma. He speaks Turkish and English.
Accepting international patientsAbout Assoc. Prof. Umut Dişel, MD
Assoc. Prof. Umut Dişel, MD is an Internal Medicine specialist who works in Medical Oncology and Internal Medicine at Acibadem Adana Hospital in Adana, Turkey. With more than 31 years in medicine, his practice centers on the medical management of solid tumors, hematologic cancers and anemia.
Dr. Dişel graduated from Çukurova University Faculty of Medicine in 1995. He completed his Internal Medicine training there in 2001 and his Medical Oncology training in 2005. In 2017 he received the title of Associate Professor in Medical Oncology, and he has been part of Acıbadem Healthcare Services since 2018. He is a member of the Medical Oncology Association and the Anadolu Medical Oncology Association. His published work in peer-reviewed journals includes articles on biliary stenting in patients with advanced cancer and biliary obstruction, acute infusion reactions to chemotherapeutic drugs, percutaneous metal stent placement in cholangiocarcinoma, and side effects associated with specific cancer medications.
Clinical focus
Dr. Dişel’s areas of expertise cover a wide range of cancers as well as anemia. On the oncology side, he provides medical treatment for breast cancer, lung and thoracic cancers, colorectal cancer, gastric cancer, liver cancer, pancreatic cancer, kidney cancer and prostate cancer. He also manages lymphoma, oral cancer, and malignant melanoma and other skin tumors. As an Internal Medicine specialist, he additionally evaluates and treats anemia.
In his oncology work, Dr. Dişel reviews the diagnosis, pathology and imaging findings that describe a patient’s disease and discusses the medical treatment options that apply to the individual situation. Where a patient has already received treatment elsewhere, previous therapies and their results form part of this assessment. His publications reflect an interest in the practical side of cancer medicine, including how treatment-related reactions and side effects are recognized and managed.
How Dr. Dişel works with international patients
Dr. Dişel speaks Turkish and English, and interpreters can be arranged for patients who speak other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports and imaging, such as MRI, CT, X-ray or ultrasound reports, laboratory and pathology results, operative notes and discharge summaries, and arranges the appointments and the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the options. For international patients, a video consultation with Dr. Dişel is also available, which can be used to review the case and discuss possible next steps before any travel is planned.
What Dr. Dişel treats and performs
Each item opens the condition or treatment page with the care pathway for international patients.
Areas of practiceInternal medicine
Conditions treated
- Anemia
- Oral cancer
- Lung and thoracic cancers
- Colorectal cancer
- Breast cancer
- Lymphoma
- Liver cancer
- Pancreatic cancer
Education, career and memberships
Education & training
Education
- 2017Medical Oncology / Associate Professor Doctor
- 2005Çukurova University Faculty of Medicine Medical Oncology
- 2001Çukurova University Faculty of Medicine Internal Medicine
- 1995Çukurova University Faculty of Medicine
Career
Professional Experience
- 2018Acıbadem Healthcare Services
Memberships
Professional Memberships
- Medical Oncology Association
- Anadolu Medical Oncology Association
Selected publications
Selected Publications
- Which patients with advanced cancer and biliary obstruction benefit from biliary stenting most? An analysis of prognostic factors Supportive Care in Cancer, 21(4), 1131-1135., Number of Citation: 2, Doi: 10.1007/s00520-012-1636-z ABALI HÜSEYİN,SEZER AHMET.Oğuzkurt Levent.GUREL KAMİL,Özkan Uğur.Beşen Ali Ayberk, SÜMBÜL AHMET TANER,KÖSE FATİH,DİŞEL UMUT
- Acute infusion reactions to chemotherapeutic drugs: A single institute experience. JOURNAL OF BALKAN UNION OF ONCOLOGY, 18(1), 261-267., Number of Citation: 1, (Control No: 1606723) MUALLAOGLU SADIK.DİŞEL UMUT.MERTSOYLU HÜSEYİN,BESEN ALI AYBERK,KARADENİZ CEMİLE, SÜMBÜL AHMET TANER.ABALI HÜSEYİN,ÖZYILKAN ÖZGÜR
- Effectiveness of percutaneous metal stent placement in cholangiocarcinoma patients with midterm follow-up: Single center experience European Journal of Radiology, 81(8), 1724-1727., Number of Citation: 3, Doi: 10.1016/j.ejrad.2011.04.056 KÖSE FATİH,OGUZKURT LEVENT.BESEN ALI AYBERK.SÜMBÜL AHMET TANER,SEZER AHMET, Karadeniz Cemile.DİŞEL UMUT.MERTSOYLU HÜSEYİN,ÖZYILKAN ÖZGÜR
- A case report of bevacizumab-related osteonecrosis of the jaw: Old problem, new culprit. Oral Oncology, 48(2), 2-3., Number of Citation: 13, Doi: 10.1016/j.oraloncology.2011.07.030, DİŞEL UMUT.Beşen Ali Ayberk.Beşen Ali Ayberk.ÖZYILKAN ÖZGÜR.Er Efsun,CANPOLAT EMİNE TUBA
- Secondary malignancy after imatinib therapy: eight cases and review of the literature Leukemia & Lymphoma, 53(9), 1706¬1708., Number of Citation: 7, Doi: 10.3109/10428194.2012.666545 BOZKURT DUMAN BERNA.PAYDAŞ SEMRA.DİŞEL UMUT BESEN AYBERK,GÜRKAN EMEL
- Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer: The Başkent University experience. Asian Pacific Journal of Cancer Prevention, 12(5), 1185-1188., Number of Citations: 1 KÖSE FATİH,BESEN ALI AYBERK.SÜMBÜL AHMET TANER,SEZER AHMET.KARADENIZ CEMİLE, DİŞEL UMUT.ALTUNDAG ÖZDEN,ÖZYILKAN ÖZGÜR
- Hypertension Associated With Angiogoenesis Inhibitors: What Do Oncologists Really Do in Daily Routine? A Small Survey The Journal of Clinical Hypertension, 13(11), 863-863., Citation: 0, Doi: 10.1111 /j.1751-7176.2011.00526. DİŞEL UMUT.ABALI HÜSEYİN.SÜMBÜL AHMET TANER.ÖZYILKAN ÖZGÜR
- Letter to the editor. Supportive Care in Cancer 18(6), 657-658., Citation: 0, Doi: 10.1007/s00520-010- 0842-9, KÖSE FATİH.Abali Huseyin.Ayberk Besen,DİŞEL UM UT, HAYRAN KADİR MUTLU
- Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine Cutaneous and Ocular Toxicology, 29(2), 140-142., Number of Citation: 5, Doi: 10.3109/15569521003699585 DİŞEL UMUT.GURKUT OZLEM.ABALI HÜSEYİN.KALEAĞASI ŞÜKRÜ HAKAN,MERTSOYLU HÜSEYİN, ÖZYILKAN ÖZGÜR.Muhammad Wasif Saif
- Severe Pulmonary Toxicity Associated with Fludarabine and Possible Contribution of Rituximab. Chemotherapy, 56(2), 89- 93., Citation Count: 5, Doi: 10.1159/000305255, DİŞEL UMUT.PAYDAŞ SEMRA,YAVUZ SİNAN,KARAKOÇ EMRE

